NCT07116486View on ClinicalTrials.gov

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2032

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

Radiopharmaceutical 18F-FSPG

Given by injection

Trial Locations (1)

77030

The University of Texas M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER